A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...

The treatment uses gene-editing tool Crispr, which earned its inventors the Nobel Prize in chemistry in 2020. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...

A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...

A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...